Transgenic T cells expressing both a CAR specific to HER2 and bearing a TCR specific for either the gp100 or OVA antigens are expanded by treatment with vaccinia expressing the cognate epitope, leading to accumulation of T cells in the tumour and eradication of large established tumours [117]. This evidence concerns the gene ERBB2 and neoplasm.